Mivacurium: a Review

Neuromuscular Blockade (GS Murphy, Section Editor)
  • 23 Downloads
Part of the following topical collections:
  1. Neuromuscular Blockade

Abstract

Purpose of Review

Mivacurium is a short-acting non-depolarizing neuromuscular-blocking agent (NMBA) which has recently been re-released onto the US market. This review provides a brief overview about the pharmacology of mivacurium and discusses its use in recent clinical practice.

Recent Findings

Mivacurium has been reported to be especially useful in the pediatric population, especially for shorter cases, and infusions can be used for longer cases without inducing tachyphylaxis. As it is rapidly metabolized by pseudocholinesterase (PChE), mivacurium does usually not require a specific reversal agent to offset its actions at the end of surgery. Especially for use in short cases, this makes it a potentially advantageous alternative to the use of other NMBA. However, deficiencies in PChE as well as old age and some drug interactions can be associated with prolonged neuromuscular blockade. The rapid administration of higher doses may provoke significant histamine release leading to hemodynamic compromise.

Summary

Despite other NMBA being available on the market and its side effects, mivacurium may still be a useful agent in short cases, particularly in the pediatric population.

Keywords

Mivacurium Neuromuscular-blocking agent Pseudocholinesterase deficiency Cardiovascular instability Drug interactions 

Notes

Compliance with Ethical Standards

Conflict of Interest

Lisa S. Molloy declares that she has no conflict of interest. Thomas Ledowski has received speaker’s honoraria and is supported by a non-related research grant from MSD, the manufacturer or rocuronium and sugammadex.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Mivacron Injection. The Electronic Medicines Compendium. 2017. https://www2.medicines.org.uk/emc/medicine/757 Accessed 10th Oct 2017.
  2. 2.
    Smith S, Scarth E, Asada M. Mivacurium In. Drugs in anaesthesia and intensive care 4th Ed. 2011 Oxford. Oxford University Press 2011 pgs 232–233.Google Scholar
  3. 3.
    • Zeng R, Liu X, Yin N, Fei J, Zhong S, Hu Z, et al. The efficacy and safety of mivacurium in paediatric patients. BMC Anesthes Open Access. 2017;17:58. A review of the use of mivacurium in various age groups in the pediatric population. CrossRefGoogle Scholar
  4. 4.
    Modolo NSM, do Nascimento Junior P, da Justa Croitor LB, PTG V, YMM C, Ganem EM, et al. Onset time and duration of rocuronium, atracurium and mivacurium in pediatric patients. Rev Bras de Anestesiol. 2002;52(2):191–6.CrossRefGoogle Scholar
  5. 5.
    • Soliday FK, Conley YP, Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired a and drug influences. AANA Jnl. 2010;78(4):313–20. This article is a comprehensive review of the genetics, drug interactions, and conditions associated with pseudocholinesterase deficiency Google Scholar
  6. 6.
    Delacour H, Lushchekina S, Mabbox I, Ceppa F, Masson P, Schopfer LM, et al. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), “silent” with mivacurium. Biochem Pharmacol. 2014;93:476–83.CrossRefGoogle Scholar
  7. 7.
    Niazi A, Leonard IE, O’Kelly B. Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency. J Clin Anes. 2004;16:40–2.CrossRefGoogle Scholar
  8. 8.
    Alibhai M, Wheatley S. Mivacurium, fixation error and human factors. HSOA J Anaes Clin Care. 2017;4:20–1.Google Scholar
  9. 9.
    Zhou W, Sheng L. Delayed recovery from paralysis associated with plasma cholinesterase deficiency. Springer Plus Open Access. 2016;5:1887.CrossRefGoogle Scholar
  10. 10.
    Cassel J, Staehr-Rye AK, Nielsen CV, Gate MR. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports. Acta Anaesthesiol Scand. 2014;53:1040–3.CrossRefGoogle Scholar
  11. 11.
    Han TH, Martyn JAJ. Neuromuscular pharmacodynamics of mivacurium in adults with major burns. BJA. 2011;106(5):675–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Martyn JAJ, Chang Y, Goudsouzian NG, Patel SS. Pharmacodynamics of mivacurium chloride in 13 - 18 year old adolescents with thermal injury. BJA. 2002;89(4):589–5.CrossRefGoogle Scholar
  13. 13.
    Martyn JAJ, Goudsouzain NG, Chang YC, Szyfelbein SK, Schwartz AE, Patel SS. Neuromuscular effects of mivacurium in 2-12 year old children with burn injury. Anesthesiology. 2000;92:31–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Tercan M, Mercanoglu EE, Turker G, Nur Kaya F, Yavascoaglu B, Ozarda Y, et al. Do metoclopromide and onadsetrone alter mivacurium-induced neuomuscular blockade?—a randomised trial. Rev Bras Anastesiol. 2014;64:34–9.Google Scholar
  15. 15.
    Skinner HJ, Girling KJ, Whitehurst A, Natheson MH. Influence of metoclopromide on plasma cholinesterase and duration of action of mivacurium. BJA. 1999;82:542–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Motomed C, Kirov K, Combes X, Dhonnev G, Duvaldestin P. Effect of metoclopromide on mivacurium induced neuromuscular block. Acta Anesthesiol Scand. 2002;46:214–6.CrossRefGoogle Scholar
  17. 17.
    Zencirci B. Sertraline induced pseudocholinesterase enzyme deficiency. Int J Gen Med. 2010;3:375–8.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    • Plaud B, Marty J, Debaene B, Meistelman C, Pellissier D, LePage JY, et al. The cardiovascular effects of mivacurium in hypertensive patients. Anaesth Analg. 2002;95:379–84. A study which compares hypertensive and normotensive and the effect of the rates of mivacurium boluses which is highly relevant to clinical practice. Google Scholar
  19. 19.
    Erol D. Bronchospasm in a pediatric adenoidectomy case. Int J Anesth. 2014;11:1.Google Scholar
  20. 20.
    Rajesh MC. Anesthesia for children with bronchial asthma and respiratory infections. Ind J Anesth. 2015;59(9):584–8.CrossRefGoogle Scholar
  21. 21.
    Fine GF, Motoyama EK, Brandom BW, Fertal KM, Mutich R, Davis PJ. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium. Anesth Analg. 2002 Jul;95(1):56–61.CrossRefPubMedGoogle Scholar
  22. 22.
    Bishop MJ, O’Donnell JT, Salemi JR. Mivacurium and bronchospasm. Anesth Analg. 2003;97:484–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Xiang Z, Yahiang Q, Ziao-Yang S, Yan-Hui Z, Min C, Guo Sheng G, et al. Effects of promethazine or dexamethasone on mivacurium induced histamine in children. Peds Anesth. 2014;24(3):322–6.CrossRefGoogle Scholar
  24. 24.
    Nagle P, Hammerle AF. Sevoflurane and mivacurium in a patient with Huntington’s chorea. BJA. 2000;85(2):320–1.CrossRefGoogle Scholar
  25. 25.
    Munster T, Schmidt HJ. Mivacurium in multicore disease. Anaesth Intensive Care. 2006;34(3):401.PubMedGoogle Scholar
  26. 26.
    Sungur Ulke Z, Senturk M. Mivacurium in patients with myasthenia graves undergoing video - assisted thorascopic thymectomy. BJA. 2009;103:310–31.CrossRefPubMedGoogle Scholar
  27. 27.
    Mizrak A, Bozgeyik S, Karakurum G, Kocamer B, Oner U. The addition of low dose mivacruium to lidocaine for intravenous regional anesthesia. J Musculoskeletal Pain. 2010;18(2):138–45.CrossRefGoogle Scholar
  28. 28.
    Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, et al. Calabadion: a new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents. Anesthesiology. 2013 Aug;119(2):317–25.CrossRefPubMedGoogle Scholar
  29. 29.
    Soto RG, Dunipace D. Mivacurium: return of a drug seeking an indication. ASA Monitor. 2017;81:30–1.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Medical School University of Western AustraliaCrawleyAustralia
  2. 2.Department of Anaesthesia and Pain MedicineRoyal Perth HospitalPerthAustralia

Personalised recommendations